Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 17;20(1):226.
doi: 10.1186/s12885-020-6703-0.

Different ODE models of tumor growth can deliver similar results

Affiliations

Different ODE models of tumor growth can deliver similar results

James A Koziol et al. BMC Cancer. .

Abstract

Background: Simeoni and colleagues introduced a compartmental model for tumor growth that has proved quite successful in modeling experimental therapeutic regimens in oncology. The model is based on a system of ordinary differential equations (ODEs), and accommodates a lag in therapeutic action through delay compartments. There is some ambiguity in the appropriate number of delay compartments, which we examine in this note.

Methods: We devised an explicit delay differential equation model that reflects the main features of the Simeoni ODE model. We evaluated the original Simeoni model and this adaptation with a sample data set of mammary tumor growth in the FVB/N-Tg(MMTVneu)202Mul/J mouse model.

Results: The experimental data evinced tumor growth heterogeneity and inter-individual diversity in response, which could be accommodated statistically through mixed models. We found little difference in goodness of fit between the original Simeoni model and the delay differential equation model relative to the sample data set.

Conclusions: One should exercise caution if asserting a particular mathematical model uniquely characterizes tumor growth curve data. The Simeoni ODE model of tumor growth is not unique in that alternative models can provide equivalent representations of tumor growth.

Keywords: Cancer chemotherapy; Delay differential equations; Mathematical model; Ordinary differential equations; Tumor growth.

PubMed Disclaimer

Conflict of interest statement

The authors declare they have no competing interests.

Figures

Fig. 1
Fig. 1
Schematic representation of the Simeoni tumor growth model. The tumor resides in compartment Z1, with growth described by a tumor growth function. c(t) denotes the plasma concentration of an anticancer agent if present. The drug elicits its effect decreasing the tumor growth rate by a factor proportional to c(t)*Z1(t) through the constant parameter k1. Tumor cells cycle successively through transit compartments Z2, Z3, Z4 before cell death. k2 is a first-order rate constant of transit. The number of transit compartments is arbitrary. The system of ordinary differential equations describing this model is given in the text
Fig. 2
Fig. 2
Schematic representation of the Simeoni tumor growth model, with transit compartments replaced by a single compartment in which tumor cell death is delayed relative to drug treatment. The delay is explicitly incorporated into the system of ordinary differential equations describing this model
Fig. 3
Fig. 3
a, b Time course of tumor growth in 21 untreated tumor-bearing mice over the course of the experiment. The X-axis (time) denotes days, and the Y-axis (volume) denotes mm3
Fig. 4
Fig. 4
Observed tumor sizes and fitted values of the 21 untreated tumor-bearing mice over the course of the experiment. The Simeoni tumor growth function was fit to the tumor size data from the entire cohort of animals, and individual fits were then derived from the mixed model analysis undertaken in Monolix
Fig. 5
Fig. 5
a, b Time course of tumor growth in 19 treated tumorbearing mice over the course of the experiment. Treatment consisted of a single dose of cisplatin (5 mg/kg) on day 0. The X-axis (time) denotes days, and the Y-axis (volume) denotes mm3
Fig. 6
Fig. 6
Observed tumor sizes and fitted values of the 19 treated tumor-bearing mice over the course of the experiment. A system of delay differential equations incorporating the Simeoni tumor growth function was fit to the tumor size data from the entire cohort of animals, and individual fits were then derived from the mixed model analysis undertaken in Monolix

Similar articles

Cited by

References

    1. Simeoni Monica, Magni Paolo, Cammia Cristiano, De Nicolao Giuseppe, Croci Valter, Pesenti Enrico, Germani Massimiliano, Poggesi Italo, Rocchetti Maurizio. Predictive Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Kinetics in Xenograft Models after Administration of Anticancer Agents. Cancer Research. 2004;64(3):1094–1101. doi: 10.1158/0008-5472.CAN-03-2524. - DOI - PubMed
    1. Magni P., Simeoni M., Poggesi I., Rocchetti M., De Nicolao G. A mathematical model to study the effects of drugs administration on tumor growth dynamics. Mathematical Biosciences. 2006;200(2):127–151. doi: 10.1016/j.mbs.2005.12.028. - DOI - PubMed
    1. Simeoni Monica, De Nicolao Giuseppe, Magni Paolo, Rocchetti Maurizio, Poggesi Italo. Modeling of human tumor xenografts and dose rationale in oncology. Drug Discovery Today: Technologies. 2013;10(3):e365–e372. doi: 10.1016/j.ddtec.2012.07.004. - DOI - PubMed
    1. Rocchetti M, Del Bene F, Germani M, Fiorentini F, Poggesi I, Pesenti E, Magni P, De Nicolao G. Testing additivity of anticancer agents in pre-clinical studies: a PK/PD modelling approach. Eur J Cancer. 2009;45:3336–3346. doi: 10.1016/j.ejca.2009.09.025. - DOI - PubMed
    1. Zhou R, Mazurchuk RV, Tamburlin JH, Harrold JM, Mager DE, Straubinger RM. Differential pharmacodynamic effects of paclitaxel formulations in an intracranial rat brain tumor model. J Pharmacol Exp Ther. 2010;332:479–488. doi: 10.1124/jpet.109.160044. - DOI - PMC - PubMed

LinkOut - more resources